Acute Myelogenous Leukemia: Genetics, Biology and Therapy (Cancer Treatment and Research)
Added: 2015-04-07 11:00:12
Acute myelogenous leukemia (AML), is the most common form of leukemia in adults. AML is a deadly form of malignancy, the prognosis for which has not improved in the last two decades. More importantly, it is a malignancy that is seen in older adults, therefore the number of cases is likely to rise as the population ages. Over the past 15 years, genetic mechanisms underlying AML have begun to unfold. Additional research in this area has helped identify key components and characteristics. Consequently, targeted therapy of AML is receiving much attention. It is the hope of researchers that as with chronic myelogenous leukemia (CML), and the drug, Gleevec, a targeted therapy for AML will be discovered.
Show more Show less 00d62a344120ee5402875735a4ff7ab4]https://novafile.com/bu8stibhi38s Size: (5.20 MB) [/code]842eb61c01ad92927c46f164e82dbb05] Bad link [/code]File name: 0387692576.pdf File size: 5.20 MB 65b0a7ab5a701582550fe97dd30a86e7]https://novafile.com/rhmpt4dfs4n7 Size: (1.80 MB) [/code]b5bdb1a333748bef00b8daf677e2fabf] Bad link [/code]File name: 0387692576.epub File size: 1.80 MB